GOLDMAN SACHS GROUP INC - GALENA BIOPHARMA INC ownership

GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 89 filers reported holding GALENA BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of GALENA BIOPHARMA INC
ValueSharesWeighting
Q3 2016$1,468,000
+1246.8%
4,191,527
+1697.0%
0.00%
Q2 2016$109,000
+98.2%
233,252
+476.8%
0.00%
Q1 2016$55,000
-3.5%
40,440
+3.7%
0.00%
Q4 2015$57,000
-64.2%
38,995
-61.3%
0.00%
Q3 2015$159,000
+15.2%
100,698
+23.8%
0.00%
Q2 2015$138,000
-47.3%
81,332
-56.8%
0.00%
Q1 2015$262,000
-34.0%
188,183
-28.4%
0.00%
Q4 2014$397,000
-38.6%
262,829
-16.3%
0.00%
Q3 2014$647,000
-52.2%
314,105
-29.0%
0.00%
Q2 2014$1,353,000
+229.2%
442,296
+169.0%
0.00%
Q1 2014$411,000
-41.4%
164,411
+16.3%
0.00%
Q4 2013$701,000
+100.9%
141,355
-7.8%
0.00%
Q3 2013$349,000
-57.6%
153,283
-58.7%
0.00%
Q2 2013$823,000
+1859.5%
370,828
+1361.3%
0.00%
Q2 2012$42,000
-48.8%
25,376
-31.2%
0.00%
Q1 2012$82,00036,8620.00%
Other shareholders
GALENA BIOPHARMA INC shareholders Q1 2015
NameSharesValueWeighting ↓
Consonance Capital Management LP 5,446,469$13,616,0002.03%
Harbour Capital Advisors, LLC 78,450$196,0000.19%
SABBY MANAGEMENT, LLC 708,089$1,770,0000.10%
TENOR CAPITAL MANAGEMENT Co., L.P. 174,600$437,0000.07%
Alyeska Investment Group, L.P. 530,000$1,950,0000.05%
HIGHLAND CAPITAL MANAGEMENT LP 528,027$1,320,0000.05%
KMS FINANCIAL SERVICES, INC 118,042$295,0000.05%
Quantitative Investment Management, LLC 348,500$871,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 538,100$1,345,0000.04%
DUMONT & BLAKE INVESTMENT ADVISORS LLC 29,675$74,0000.04%
View complete list of GALENA BIOPHARMA INC shareholders